Cerebrospinal fluid tissue transglutaminase in vascular dementia
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 203-204, 207-209
- https://doi.org/10.1016/s0022-510x(02)00292-7
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Vascular dementia: A diagnosis running out of timeThe British Journal of Psychiatry, 2002
- Clinicopathological Validation Study of Four Sets of Clinical Criteria for Vascular DementiaAmerican Journal of Psychiatry, 2002
- A review of the epidemiological transition in dementia — cross‐national comparisons of the indices related to Alzheimer's disease and vascular dementiaActa Psychiatrica Scandinavica, 2001
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- Relationship between apoE genotype and CSF β-amyloid (1–42) and tau in patients with probable and definite Alzheimer's diseaseNeurobiology of Aging, 2000
- Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's diseaseNeuroscience Letters, 2000
- A Unifying Hypothesis of Alzheimer's Disease. IV. Causation and Sequence of EventsReviews in the Neurosciences, 2000
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 1987
- Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filamentsJournal of the Neurological Sciences, 1986
- Amyloid plaque core protein in Alzheimer disease and Down syndrome.Proceedings of the National Academy of Sciences, 1985